Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Vascular-based compartmental resection of anterior clinoidal meningiomas: an inter-perforator microdebulking strategy.
Acta neurochirurgica·2026
Same author
Refined Endoscopic Extracapsular Resection Technique for Pituitary Adenomas With Suprasellar Extension: A Retrospective Analysis of 259 Cases.
Operative neurosurgery (Hagerstown, Md.)·2026
Related Experiment Video
Updated: Jun 25, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.
Takanori Akagi1, Takemasa Matsumoto, Taishi Harada
1Department of Respiratory Medicine, Fukuoka University School of Medicine, 7-45-1, Nanakuma, Jonanku, Fukuoka 814-0180, Japan.
Respiratory Medicine
|March 3, 2009
Summary
Patients with combined pulmonary fibrosis and emphysema (CPFE) show slower respiratory function decline and similar survival compared to idiopathic pulmonary fibrosis (IPF) alone. Emphysema co-existence may mitigate ventilatory and gas-exchange deterioration in IPF.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Research
Background:
- Yearly changes in respiratory function for combined pulmonary fibrosis and emphysema (CPFE) are not well-documented.
- Previous studies have focused on single data points rather than longitudinal changes.
Purpose of the Study:
- To quantify annual respiratory function changes in CPFE patients.
- To compare survival rates between CPFE and idiopathic pulmonary fibrosis (IPF) alone patients.
- To investigate the impact of emphysema on IPF progression.
Main Methods:
- Retrospective analysis of 26 CPFE and 33 IPF alone patients with at least one year of respiratory function monitoring.
- Comparison of baseline and annual changes in vital capacity percent predicted (VC% pred), forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC%), and diffusing capacity percent predicted (DLco% pred).
- Kaplan-Meier survival analysis.
Main Results:
- CPFE patients had higher baseline VC% pred but significantly slower annual decreases in VC% pred and DLco% pred compared to IPF alone patients.
- FEV1/FVC% tended to decrease annually in CPFE patients, whereas it increased in IPF alone patients.
- No significant difference in survival duration was observed between the two groups.
Conclusions:
- The presence of emphysema in CPFE patients appears to slow the deterioration of respiratory function and gas exchange compared to IPF alone.
- Co-existing emphysema may have a protective effect against severe ventilatory decline in IPF.
- Annual monitoring is crucial for understanding disease progression in these complex respiratory conditions.